165 related articles for article (PubMed ID: 37278169)
1. [Hereditary pulmonary hypertension family with
Lin YK; Yang DH; Lei C; Luo H
Zhonghua Jie He He Hu Xi Za Zhi; 2023 Jun; 46(6):558-564. PubMed ID: 37278169
[No Abstract] [Full Text] [Related]
2. BMPR2 mutation in a patient with pulmonary arterial hypertension and suspected hereditary hemorrhagic telangiectasia.
Rigelsky CM; Jennings C; Lehtonen R; Minai OA; Eng C; Aldred MA
Am J Med Genet A; 2008 Oct; 146A(19):2551-6. PubMed ID: 18792970
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary arterial hypertension and portal hypertension in a patient with hereditary hemorrhagic telangiectasia.
Pousada G; Baloira A; Valverde D
Med Clin (Barc); 2015 Mar; 144(6):261-4. PubMed ID: 25543221
[TBL] [Abstract][Full Text] [Related]
4. Mutational and clinical spectrum of Japanese patients with hereditary hemorrhagic telangiectasia.
Kitayama K; Ishiguro T; Komiyama M; Morisaki T; Morisaki H; Minase G; Hamanaka K; Miyatake S; Matsumoto N; Kato M; Takahashi T; Yorifuji T
BMC Med Genomics; 2021 Dec; 14(1):288. PubMed ID: 34872578
[TBL] [Abstract][Full Text] [Related]
5. Heart failure and pulmonary arteriovenous malformations in a patient with hereditary hemorrhagic telangiectasia type 2.
Du J; Zhu Y; Zhang YL; Li S; Huang J; Luo XH; Liu L
J Thromb Thrombolysis; 2015 Nov; 40(4):515-9. PubMed ID: 26245826
[TBL] [Abstract][Full Text] [Related]
6. Clinical features and mutations in the ENG, ACVRL1, and SMAD4 genes in Korean patients with hereditary hemorrhagic telangiectasia.
Lee ST; Kim JA; Jang SY; Kim DK; Do YS; Suh GY; Kim JW; Ki CS
J Korean Med Sci; 2009 Feb; 24(1):69-76. PubMed ID: 19270816
[TBL] [Abstract][Full Text] [Related]
7. A novel BMPR2 mutation in a patient with heritable pulmonary arterial hypertension and suspected hereditary hemorrhagic telangiectasia: A case report.
Ye F; Jiang W; Lin W; Wang Y; Chen H; Zou H; Huang S; Zhu N; Han S
Medicine (Baltimore); 2020 Jul; 99(31):e21342. PubMed ID: 32756122
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary arterial hypertension in hereditary hemorrhagic telangiectasia associated with ACVRL1 mutation: a case report.
Walsh LJ; Collins C; Ibrahim H; Kerins DM; Brady AP; O Connor TM
J Med Case Rep; 2022 Mar; 16(1):99. PubMed ID: 35232468
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary Hypertension and Hereditary Hemorrhagic Telangiectasia Related to an ACVRL1 Mutation.
Yokokawa T; Sugimoto K; Kimishima Y; Misaka T; Yoshihisa A; Morisaki H; Yamada O; Nakazato K; Ishida T; Takeishi Y
Intern Med; 2020 Jan; 59(2):221-227. PubMed ID: 31511490
[TBL] [Abstract][Full Text] [Related]
10. Identification and validation of a novel pathogenic variant in GDF2 (BMP9) responsible for hereditary hemorrhagic telangiectasia and pulmonary arteriovenous malformations.
Balachandar S; Graves TJ; Shimonty A; Kerr K; Kilner J; Xiao S; Slade R; Sroya M; Alikian M; Curetean E; Thomas E; McConnell VPM; McKee S; Boardman-Pretty F; Devereau A; Fowler TA; Caulfield MJ; Alton EW; Ferguson T; Redhead J; McKnight AJ; Thomas GA; ; Aldred MA; Shovlin CL
Am J Med Genet A; 2022 Mar; 188(3):959-964. PubMed ID: 34904380
[TBL] [Abstract][Full Text] [Related]
11. Clinical features of pulmonary arterial hypertension in young people with an ALK1 mutation and hereditary haemorrhagic telangiectasia.
Smoot LB; Obler D; McElhinney DB; Boardman K; Wu BL; Lip V; Mullen MP
Arch Dis Child; 2009 Jul; 94(7):506-11. PubMed ID: 19357124
[TBL] [Abstract][Full Text] [Related]
12. Mutations in the ENG, ACVRL1, and SMAD4 genes and clinical manifestations of hereditary haemorrhagic telangiectasia: experience from the Center for Osler's Disease, Uppsala University Hospital.
Karlsson T; Cherif H
Ups J Med Sci; 2018 Sep; 123(3):153-157. PubMed ID: 30251589
[TBL] [Abstract][Full Text] [Related]
13. Mutation affecting the proximal promoter of Endoglin as the origin of hereditary hemorrhagic telangiectasia type 1.
Albiñana V; Zafra MP; Colau J; Zarrabeitia R; Recio-Poveda L; Olavarrieta L; Pérez-Pérez J; Botella LM
BMC Med Genet; 2017 Feb; 18(1):20. PubMed ID: 28231770
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcomes of pulmonary arterial hypertension in patients carrying an ACVRL1 (ALK1) mutation.
Girerd B; Montani D; Coulet F; Sztrymf B; Yaici A; Jaïs X; Tregouet D; Reis A; Drouin-Garraud V; Fraisse A; Sitbon O; O'Callaghan DS; Simonneau G; Soubrier F; Humbert M
Am J Respir Crit Care Med; 2010 Apr; 181(8):851-61. PubMed ID: 20056902
[TBL] [Abstract][Full Text] [Related]
15. Variant analysis in Chinese families with hereditary hemorrhagic telangiectasia.
Zhao Y; Zhang Y; Wang X; Zhang L
Mol Genet Genomic Med; 2019 Sep; 7(9):e893. PubMed ID: 31400083
[TBL] [Abstract][Full Text] [Related]
16. Clinical and molecular characterization of patients with hereditary hemorrhagic telangiectasia: Experience from an HHT Center of Excellence.
Latif MA; Sobreira NLD; Guthrie KS; Motaghi M; Robinson GM; Shafaat O; Gong AJ; Weiss CR
Am J Med Genet A; 2021 Jul; 185(7):1981-1990. PubMed ID: 33768677
[TBL] [Abstract][Full Text] [Related]
17. Clinical and genetic characteristics of Chinese patients with hereditary haemorrhagic telangiectasia-associated pulmonary hypertension.
Chen YJ; Yang QH; Liu D; Liu QQ; Eyries M; Wen L; Wu WH; Jiang X; Yuan P; Zhang R; Soubrier F; Jing ZC
Eur J Clin Invest; 2013 Oct; 43(10):1016-24. PubMed ID: 23919827
[TBL] [Abstract][Full Text] [Related]
18. [Genetic diagnostics of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease)].
Major T; Gindele R; Szabó Z; Jóni N; Kis Z; Bora L; Bárdossy P; Rácz T; Karosi T; Bereczky Z
Orv Hetil; 2019 May; 160(18):710-719. PubMed ID: 31030535
[TBL] [Abstract][Full Text] [Related]
19. Distribution of ENG and ACVRL1 (ALK1) mutations in French HHT patients.
Lesca G; Burnichon N; Raux G; Tosi M; Pinson S; Marion MJ; Babin E; Gilbert-Dussardier B; Rivière S; Goizet C; Faivre L; Plauchu H; Frébourg T; Calender A; Giraud S;
Hum Mutat; 2006 Jun; 27(6):598. PubMed ID: 16705692
[TBL] [Abstract][Full Text] [Related]
20. Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia.
Harrison RE; Flanagan JA; Sankelo M; Abdalla SA; Rowell J; Machado RD; Elliott CG; Robbins IM; Olschewski H; McLaughlin V; Gruenig E; Kermeen F; Halme M; Räisänen-Sokolowski A; Laitinen T; Morrell NW; Trembath RC
J Med Genet; 2003 Dec; 40(12):865-71. PubMed ID: 14684682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
